ArthroCare lands FDA win for SpeedLock HIP implant

March 5, 2013 by Arezu Sarvestani

Medical device maker ArthroCare wins FDA clearance for its SpeedLock HIP implant for soft tissue-to-bone fixation in the hip.

Arthrocare logo

Surgical devices maker ArthroCare (NSDQ:ARTC) won FDA clearance for its SpeedLock HIP implant, a soft-tissue-to-bone fixation implant for hip repair surgeries.

The device's primary use is in acetabular labral reattachment and hip capsular repair, according to a press release.

Sign up to get our free newsletters delivered right to your inbox.

The SpeedLock implant is part of ArthroCare's Coblation line of wands and suturing technologies. The implant is designed to "provide a precise and stable construct with a streamlined technique," ArthroCare said.

The Austin, Texas-based medical device company recently reported a return to profitability in the 4th quarter and full year of 2012, but analysts are wary as ArthroCare continues to weather Justice Dept. investigations.

The Austin, Texas based medical device company last month agreed to extend the statute of limitations on a DoJ probe into its spinal business that dates back to 2008. The surgical instruments maker is also facing a federal look at possible False Care Act violations.